Protocol Design

  • Uploaded by: api-3810976
  • 0
  • 0
  • November 2019
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Protocol Design as PDF for free.

More details

  • Words: 365
  • Pages: 15
PROTOCOL DESIGN

Dr. JAYASHREE ICRI

DEFINITION AND PURPOSE 

  

A Document that describes the objectives,design,methodology and statistical considerations and organisation of a trial Background and rationale for the trial Protocol amendments Content and format-SOP

Why ,how,what

PROTOCOL  Protocol

to be comprehensive-users  Information to study site staff  Data collection and analysis.  Clinical study report

PROTOCOL –INPUTS  Staff

of the sponsor company  Regulatory affairs department  Marketing department  Medical literature  Investigators brochure  statistician

OBJECTIVES OF THE STUDY  Precise

and clearly defined  As few as possible  What can the results demonstrate – Primary objective – Secondary objective

PATIENT SELECTION  Criteria

for inclusion and exclusion  Inclusion – Evidence to confirm the diagnosis  Exclusion

– Concomitant medication – Concomitant disease – Contra-indications

TRIAL DESIGN  Study,phase,end-point

of study

– Comparator or non comparator – Cross-over or parallel group  Choice

of comparator

 Bias

– Selection or allocation bias – Observer bias

METHODOLOGY 

Treatment material – – – – – – – –

Blinding method Quantities Period of use Compliance checking Packaging Labelling Storage and handling Escape medication and concomitant medication

METHODOLOGY 

Patient management – – – – –



Schedule of events Investigations-central lab,relevant inv Adverse affects treatment-by ,to ,when Patient instructions Records and data collection-source documents,entry in to CRF , direct entry into CRF.

Assesment of efficacy and safety.

STATISTICAL CONSIDERATIONS  DESIGN  COMPARATOR-PROS  SAMPLE

AND CONS

SIZE  STATISTICAL ANALYSIS

ETHICAL CONSIDERATIONS  Basis

for the study should be ethical from subject’s point of view – Ensure safety – Invasive investigations – Use of placebo

 IC,confidentiality,compensation,

indemnity,audit and finance

ORGANISATION, PRACTICALITIES  Commitment

of all participants  Cultural variabilities

TRIAL ADMINISTRATION  Co

ordination – staff,monitor  Responsibility – regulatory authorities,maintain data,ADR monitor  Agreement – between company ,investigator,regulatory bodies.  Funding ALL ACCORDING TO COMPANY SOP.

PROTOCOL REVIEW AND SIGN -OFF  Circulated

for critical review  Protocol writer-editor with a team  Committee of individuals specified in the SOP

PROTOCOL AMENDMENTS  Minimum  Procedure

for dealing and tracking amendments are defined in SOP  Review and sign off, ethics committee approval

Related Documents

Protocol Design
November 2019 23
Protocol Design Phase
June 2020 11
Protocol
November 2019 45
Protocol
June 2020 24
Protocol
April 2020 32
Protocol
October 2019 45